| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), ADAPY's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Lunger John | Chief Patient Supply Officer | Sell | 9,229 | $0.85 | $7,812.73 | -54.0% | |
| Jan 12, 2024 | Bertrand William C Jr | Chief Operating Officer | Sell | 9,229 | $0.85 | $7,812.73 | -54.0% | |
| Sep 1, 2023 | Rawcliffe Adrian | Chief Executive Officer | Sell | 2,403 | $0.78 | $1,874.34 | -41.1% | |
| Aug 1, 2023 | Lunger John | Chief Patient Supply Officer | Sell | 3,096 | $0.91 | $2,803.74 | -39.6% | |
| Jul 10, 2023 | Menzel Garry E | Director | Sell | 47,702 | $0.91 | $43,446.98 | -38.9% | |
| Jun 27, 2023 | Rawcliffe Adrian | Chief Executive Officer | Sell | 2,333 | $0.92 | $2,146.36 | -39.9% | |
| Jan 31, 2023 | Piccina Cintia | Chief Commercial Officer | Sell | 11,890 | $1.87 | $22,229.54 | -37.8% | |
| Jan 17, 2023 | Rawcliffe Adrian | Chief Executive Officer | Sell | 10,057 | $1.86 | $18,685.91 | -43.0% | |
| Jan 17, 2023 | Norry Elliot | Chief Medical Officer | Sell | 2,159 | $1.86 | $4,011.42 | -38.2% | |
| Jan 17, 2023 | Bertrand William C Jr | Chief Operating Officer | Sell | 4,440 | $1.86 | $8,249.52 | -37.9% |